Andrew Walsh
CIK: 0002068849
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ANVS
Annovis Bio, Inc.
Officer
Discretionary Trading P&L
Holdings
About Walsh Andrew
Walsh Andrew (SEC CIK 0002068849) files insider reports with the SEC as Vice President, Finance of Annovis Bio, Inc. (ANVS).
Signal8 holds 2 ownership filings by Walsh Andrew (1 Form 3, 1 Form 4), filed between May 16, 2025 and Jun 18, 2025. Those filings report 1 transaction, the latest on Jun 16, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Walsh Andrew's filings is in MALVERN, PA.
Recent filings by Walsh Andrew
- Jun 16, 2025: Grant or award of ANVS shares (Form 4, code A).
Other insiders filing for Annovis Bio, Inc. (ANVS)
- Hoffman Michael B, Director
- Maccecchini Maria-Luisa, President & CEO
- Bruck Claudine, Director
- McCarthy Reid, Director